286PDPost-treatment biopsies show evidence of cell cycle arrest and immune cell infiltration into tumors of ladiratuzumab vedotin-treated advanced breast cancer patients. (23rd October 2018) - Specht, J; Pusztai, L; Forero-Torres, A; Mita, M; Weise, A; Krop, I; Grosse-Wilde, A; Wang, Z; Li, M; Hengel, S; Garfin, P; Means, G; et al.